Capital Markets Crystal Ball: Strategies for Equity Financing

Access to capital is the lifeblood of biotech drug development. There are a number of avenues for raising capital, each with its own set of pros and cons, and various options seemingly falling in and out of favor as the market waxes and wanes. Gain perspective on navigating these options from some of the largest fundraisers of the past year, listen to their strategies and lessons learned from financing their drug development endeavors, and hear their predictions for what the markets may bring in the year ahead. The audience will be able to make their predictions and compare with our esteemed panelists.

Please note this session was pre-recorded but make sure to engage in the live Q & A chat.
BIO’s President & CEO, Dr. Michelle McMurry-Heath will hold a moment of silence for George Floyd during the plenary session at 11:00 am PDT.